logo

For the Inventor, By the Inventor

Seoul, South Korea

Dong Wha Pharmaceutical Co. Ltd.


USPTO Granted Patents = 10



Forward Citations = 11

Loading Chart...
Loading Chart...

34 inventors (with patents filed for the assignee):

goldMedal Jei Man Ryu (9 out of 17 patents)

silverMedal Jin Soo Lee (8 out of 173 patents)

bronzeMedal Yun-Ha Hwang (5 out of 5 patents)

4.  Sae Kwang Ku (4 out of 15 patents)

5.  Young Goo Jin (4 out of 5 patents)

6.  Hong-Suk Suh (3 out of 3 patents)

7.  Pan-Soo Kim (3 out of 3 patents)

8.  Yong-Ho Chung (3 out of 4 patents)

9.  Eun-Joo Kim (3 out of 4 patents)

10.  Do-Hui Kim (3 out of 3 patents)

11.  Yong-Youp Park (3 out of 3 patents)

12.  Jae Hoon Park (3 out of 4 patents)

13.  Yun Ha Hwang (2 out of 3 patents)

14.  Jin Sung Yang (1 out of 3 patents)

15.  Jin-soo Lee (1 out of 6 patents)


10 patents:

1. 8324238 - Aspartate of 1-cyclopropyl-6-fluoro-7-(8-methoxyimino-2,6-diaza-spiro[3.4]oct-6-yl)-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid, method for preparing the same, and antimicrobial pharmaceutical composition comprising the same (2012-12-04),
2. 8242152 - Use of 4-[(4-thiazolyl)phenoxy]alkoxy-benzamidine derivatives for the prophylaxis and treatment of osteoporosis (2012-08-14),
3. 8227496 - Use of 4-[(4-thiazolyl)phenoxy]alkoxy-benzamidine derivatives for treatment of osteoporosis (2012-07-24),
4. 8178688 - Benzamidine derivatives, process for the preparation thereof and pharmaceutical composition comprising the same (2012-05-15),
5. 8039635 - N-hydroxy-4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl) phenoxy]pentoxy} benzamidine 2 ethansulfonic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same (2011-10-18),
6. 8008329 - Method of treating or preventing osteoporosis comprising administering to a patient in need thereof an effective amount of pharmacuetical composition comprising benzamidine derivative or it's salt, and bisphosphonate (2011-08-30),
7. 7964584 - Method of treating or preventing osteoporosis comprising administering to a patient in need thereof an effective amount of pharmaceutical composition comprising benzamidine derivatives or their salts, and alendronic acid or its salt (2011-06-21),
8. 7943646 - Benzamidine derivative, process for the preparation thereof and pharmaceutical composition comprising same (2011-05-17),
9. 7923443 - Pharmaceutical composition for the treatment of bone fracture (2011-04-12),
10. 7662840 - Use of 4-[(4-thiazolyl)phenoxy]alkoxy-benzamidine derivatives for treatment of osteoporosis (2010-02-16),
Dong Wha Pharmaceutical Co. Ltd. is a leading pharmaceutical company based in South Korea. Established in 1897, the company has a strong presence in the Korean pharmaceutical market and has expanded its reach globally. Dong Wha Pharmaceutical focuses on developing and manufacturing high-quality pharmaceutical products to improve the health and well-being of people around the world.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

10 Patents

#341 in Seoul

#1,035 in South Korea

#54,348 in the World

...
Seoul, South Korea

Dong Wha Pharmaceutical Co. Ltd.

Forward Citations = 11

34 inventors:

goldMedal Jei Man Ryu (9 out of 17 patents)

silverMedal Jin Soo Lee (8 out of 173 patents)

bronzeMedal Yun-Ha Hwang (5 out of 5 patents)

4.  Sae Kwang Ku (4 out of 15 patents)

5.  Young Goo Jin (4 out of 5 patents)

Please report any incorrect information to support@idiyas.com
Loading…